- £212.05bn
- £230.23bn
- $54.07bn
- 85
- 15
- 94
- 76
REG - AstraZeneca PLC - AstraZeneca to acquire EsoBiotec
AnnouncementREG - AstraZeneca PLC - Imfinzi approved in EU for limited-stage SCLC
AnnouncementREG - AstraZeneca PLC - Eneboparatide Phase III trial met primary endpoint
AnnouncementREG - AstraZeneca PLC - Holding(s) in Company
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Notice of AGM
AnnouncementREG - AstraZeneca PLC - Imfinzi improved EFS in early-stage gastric cancer
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Imfinzi recommended for EU approval for AEGEAN
AnnouncementREG - AstraZeneca PLC - Enhertu recommended in EU in post-ET breast cancer
AnnouncementREG - AstraZeneca PLC - Camizestrant improved PFS in 1L HR+ breast cancer
AnnouncementREG - Redx Pharma Limited - Phase 1 Data on RXC008 Presented at ECCO
AnnouncementREG - AstraZeneca PLC - Filing of Form 20-F with SEC
AnnouncementREG - AstraZeneca PLC - Holding(s) in Company
AnnouncementREG - AstraZeneca PLC - Annual Financial Report
AnnouncementREG - AstraZeneca PLC - Directorate Change
AnnouncementREG - AstraZeneca PLC - Final Results
Announcement